Fertility Supplements Market To Hit Value .39 Billion By 2025 |Grand View Rese

Posted by Mrudula Karmarkar on December 28th, 2021

The global fertility supplements market size is projected to reach USD 2.39 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.4% during the forecast period. The declining fertility rates owing to the rise in consumption of alcohol, caffeine, and cigarettes is anticipated to fuel the demand for fertility supplements.

OTC fertility supplement segment is expected to witness significant growth in emerging economies owing to the rising consumer awareness regarding the health benefits and nutritional value of these products. Self-medication, cost effectiveness, and convenience of direct purchase is expected to boost the demand of fertility supplements over the forecast period.

Factors such as growing geriatric population and rising interest for preventive healthcare have surged the demand for herbal fertility supplements, in turn spurring the growth of the fertility supplements market. Consumers are looking for ingredients such as grape seed extracts, primrose oil, and red clover in products having minimum side effects and high efficiencies. Manufacturers are focusing on providing a blend of natural and synthetic ingredients to cater to consumer demand across the globe.

Government policies like ‘one-child-per-couple’ subjected to forced sterilizations or abortions resulted in decreasing the fertility of women. However, abolishment of one and two child per couple policies and major amendments in family planning regulations are expected to have a positive effect on fertility rate. This factor is anticipated to hinder the market growth in China.

Rising number of doctors in Italy for initiating the advice for their patients to consume fertility supplements to help them to cope up with fertility issues, in combination with Rx-medicine based therapies is expected to remain a favorable factor for the market.

According to the American Society for Reproductive Medicine, in the U.S., approximately 35% and 30% of men and women of reproductive age smoke cigarettes. The prevalence of smoking is higher in developed countries than in emerging economies. Even fertility treatments such as IVF may not be helpful in conceiving for smoking women, which has prompted fertility manufacturers to look for ingredients that can eliminate the effects of smoking on fertility. This factor is anticipated to create growth opportunities for the fertility supplement manufacturers over the forecast period.

Have a Query? Ask our experts:


Increasing importance of food products such as avocados, olive oil, whole grains, and high fat dairy products used in increasing fertility is expected to amplify the scope of functional food and beverages in the near future resulting in hindering the overall growth. Increasing adoption of herbal medicines (botanicals) owing to rising concerns regarding the harmful effects associated with traditional pharma drugs is anticipated to create growth opportunities for the product manufacturers. Various government initiatives for creating awareness about the advancements in supplement research and superior technology have helped consumers make supplement choices based on what is good for their health rather than picking products on the basis of packaging and impressive marketing.

Further key findings from the report suggest:

  • In terms of revenue, natural fertility supplements is projected to ascend at a CAGR of 8.6% over the forecast period
  • Tablets and capsules segment contributed approximately over 68.7% to the total market in 2018
  • Over the counter fertility supplements led the market in 2018, constituting a revenue share of over 79.3% in 2018
  • Asia Pacific is expected to witness the fastest growth over the forecast period. Expansion of retail chains in countries such as India, Japan, and China has increased the dietary supplements consumption in this region
  • The fertility supplements market represents a highly competitive landscape. Key players dominating the market space have been focusing on various strategic initiatives including mergers and acquisitions, product innovation, and portfolio expansion
  • Key participants in the market include Fairhaven Health, Orthomol, Vitabiotics, TTK Healthcare, Lenus Pharma among others

Over the past few years, the consumers from Brazil and Argentina are focusing on improving sexual health as well as wellbeing, and as a result are willing to spend more money on the relevant products which is anticipated to surge the demand for fertility supplements over the next seven years.

Manufacturers are aiming to improve treatment success rates and treatment experience. Companies such as Orthomol, TTK HealthCare, and Fairhaven Health are putting a strong emphasis on extending and innovating their portfolio to provide support to people wanting a baby. Companies continue to advance innovation in fertility supplements to increase success rates through life cycle management, which is also inclusive of new indications and new combinations.

Leading fertility supplement manufacturers are focusing on providing new products by investing in R&D along with technological advancements to provide cost-effective products with superior quality. Market players are entering into joint ventures, partnerships, mergers, agreements, and acquisitions to strengthen their market share and expand their geographical reach. Companies are also focusing on raising awareness among consumers regarding the ambiguity concerning the ingredients used, while strictly adhering to international regulatory standards.

Like it? Share it!

Mrudula Karmarkar

About the Author

Mrudula Karmarkar
Joined: March 30th, 2020
Articles Posted: 395

More by this author